Company intelligence / Profile preview
Maxwellia
Alderley Edge, England, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Maxwellia is a consumer healthcare company specializing in 'switching' prescription medicines to over-the-counter (OTC) status, focusing on women's health. Its current OTC brands include Ultravana (naproxen) for period pain, Evana (tranexamic acid) for heavy menstrual bleeding, Lovima (progestogen-only pill) for daily contraception, and LoviOne (ulipristal acetate) for emergency contraception. These products are already commercially available in the UK.
- Therapeutic areas
- Women's Health
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Maxwellia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maxwellia.